Unique ID issued by UMIN | UMIN000016052 |
---|---|
Receipt number | R000018656 |
Scientific Title | Efficacy of IOP reduction and safety of Tapcom combination ophthalmic solution switched from Tapros 0.0015% and Timoptol XE 0.5% ophthalmic solution. |
Date of disclosure of the study information | 2014/12/29 |
Last modified on | 2018/04/02 14:37:14 |
Efficacy of IOP reduction and safety of Tapcom combination ophthalmic solution switched from Tapros 0.0015% and Timoptol XE 0.5% ophthalmic solution.
Efficacy of IOP reduction and safety of Tapcom combination ophthalmic solution switched from Tapros 0.0015% and Timoptol XE 0.5% ophthalmic solution.
Efficacy of IOP reduction and safety of Tapcom combination ophthalmic solution switched from Tapros 0.0015% and Timoptol XE 0.5% ophthalmic solution.
Efficacy of IOP reduction and safety of Tapcom combination ophthalmic solution switched from Tapros 0.0015% and Timoptol XE 0.5% ophthalmic solution.
Japan |
primary open angle glaucoma or ocular hypertension
Ophthalmology |
Others
NO
To investigate efficacy of IOP reduction and safety of Tapcom combination ophthalmic solution switched from Tapros 0.0015% and Timoptol XE 0.5% ophthalmic solution.
Safety,Efficacy
IOP reduction
Adverse event
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
Switching from Tapros 0.0015% and Timoptol XE 0.5% ophthalmic solution to Tapcom combination ophthalmic solution
20 | years-old | <= |
Not applicable |
Male and Female
primary open angle glaucoma or ocular hypertension
good adherence before the study initiation
some corneal abnormality or other diseases which may interfere with accurate IOP measurement
history of glaucoma surgery
contraindicated to Beta blockers
30
1st name | |
Middle name | |
Last name | 1.Kenji Inoue 2.Masayo Hashimoto |
1.Inouye Eye Hospital 2.Santen Pharmaceutical Co., Ltd.
1.Medical office 2.Japan Medical Affairs Group, Development Management Department, Japan Business
1.4-3 Kanda Surugadai, Chiyoda-Tokyo, Japan 2. 4-20, Ofukacho, Kita-ku, Osaka
1.03-3295-0911
1.study@inouye-eye.or.jp
1st name | |
Middle name | |
Last name | Kenji Inoue |
Inouye Eye Hospital
Medical office
4-3 Kanda Surugadai, Chiyoda-Tokyo, Japan
03-3295-0911
study@inouye-eye.or.jp
Inouye Eye Hospital
Santen Pharmaceutical Co., Ltd.
Profit organization
NO
医療法人社団 済安堂 お茶の水・井上眼科クリニック(東京都)/
Medical Corporation Saiando Ochanomizu Inouye eye clinic
2014 | Year | 12 | Month | 29 | Day |
Published
https://doi.org/10.2147/OPTH.S150595
Completed
2014 | Year | 12 | Month | 06 | Day |
2014 | Year | 12 | Month | 12 | Day |
2014 | Year | 12 | Month | 25 | Day |
2018 | Year | 04 | Month | 02 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018656
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |